Maravai returns to ex‑COVID growth with positive Q4 2025 EBITDA, guides 2026 revenue $200–$210M and EBITDA $18–$20M
- Ex‑COVID, Q4 revenue grew 18% and adjusted EBITDA turned positive ahead of plan.
- Maravai beat Q4 2025 EPS and revenue estimates with non-GAAP EPS $-0.04, +33% YoY, on revenue $49.9M, -12% YoY.
- Full-year 2025 revenue was $185.7M, modestly above guidance by about $0.7M.
- TriLink base Q4 revenue rose 25% ex‑COVID; full-year base revenue fell 8%.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.